rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michael Edward Sherman

Director

Company insider

Files Form 4 as: Director, BioVie; Director, Ontrak.

In numbers

Trades disclosed
48
Buys
2
Sells
1
Bought
$75K
Sold
$306
Companies
2
Companies where not an officer
2
First trade
19 Dec 2017
Last trade
5 Jan 2026
Last filed
9 Jan 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
BIVI BioVieDirector · Biotechnology · last 5 Jan 20260 buys · 0 sells
OntrakDirector · last 2 Jan 20252 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 Jan 2026filed 9 Jan 2026BIVI BioVieoption or derivative · BiotechnologySEC FORM 4 Code A—80,000 at $0.00filing
5 Jan 2026filed 9 Jan 2026BIVI BioVieoption or derivative · BiotechnologySEC FORM 4 Code A—341,100 at $0.00filing
5 Jan 2026filed 9 Jan 2026BIVI BioVieoption or derivative · BiotechnologySEC FORM 4 Code A—80,000 at $0.00filing
5 Jan 2026filed 9 Jan 2026BIVI BioVieoption or derivative · BiotechnologySEC FORM 4 Code A—341,100 at $0.00filing
2 Jan 2025filed 6 Jan 2025Ontrakoption or derivativeSEC FORM 4 Code A—91,829 at $0.00filing
20 Dec 2024filed 7 Jan 2025BIVI BioVieoption or derivative · BiotechnologySEC FORM 4 Code A—23,325 at $0.00filing
20 Nov 2024filed 7 Jan 2025BIVI BioVieoption or derivative · BiotechnologySEC FORM 4 Code A—56,900 at $0.00filing
20 Nov 2024filed 22 Nov 2024OntrakSEC FORM 4 Sold$306173 at $1.77filing
10 Sep 2024filed 12 Sep 2024Ontrakoption or derivativeSEC FORM 4 Code A—4,166,667 at $0.00filing
2 Jan 2024filed 4 Jan 2024Ontrakoption or derivativeSEC FORM 4 Code A—332,333 at $0.00filing
9 Nov 2023filed 6 Dec 2023BIVI BioVieoption or derivative · BiotechnologySEC FORM 4 Code A—89,750 at $0.00filing
3 Jan 2023filed 5 Jan 2023Ontrakoption or derivativeSEC FORM 4 Code A—321,345 at $0.00filing
23 Nov 2022filed 18 Jan 2023BIVI BioVieoption or derivative · BiotechnologySEC FORM 4 Code A—75,000 at $0.00filing
29 Aug 2022filed 26 Dec 2023Ontrakoption or derivativeSEC FORM 4 Code A—460,759 at $0.00filing
29 Aug 2022filed 31 Aug 2022Ontrakoption or derivativeSEC FORM 4 Code A—61,040filing
29 Aug 2022filed 31 Aug 2022Ontrakoption or derivativeSEC FORM 4 Code D—61,040filing
29 Aug 2022filed 31 Aug 2022Ontrakoption or derivativeSEC FORM 4 Code A—37,794filing
29 Aug 2022filed 31 Aug 2022Ontrakoption or derivativeSEC FORM 4 Code D—37,794filing
29 Aug 2022filed 31 Aug 2022Ontrakoption or derivativeSEC FORM 4 Code A—16,630filing
29 Aug 2022filed 31 Aug 2022Ontrakoption or derivativeSEC FORM 4 Code D—16,630filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Joanne Wendy KimChief Financial Officer · Chief Financial Officer at Biovie, filing Form 4 there in the last year
Cuong Do VPresident & CEO · President & CEO at Biovie, filing Form 4 there in the last year
Joseph M. PalumboChief Medical Officer · Chief Medical Officer at Biovie, filing Form 4 there in the last year
Amy Suzon ChappellDirector · Director at Biovie, filing Form 4 there in the last year
Kameel D. FaragInterim CFO · Director at Biovie, filing Form 4 there in the last year